Skip to content
10-K

Annual Report

CABALETTA BIO, INC. CABA

0001759138-26-000011

← back to feed
Filed
Mar 23, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 19, 2026 111.32M sh
Capex FY 2025 · Dec 31, 2025 $1.23M
Capex FY 2025 · Dec 31, 2024 $2.21M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$131.08M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$88.22M
Short Term Investments FY 2025 · Dec 31, 2025 $50.62M
Short Term Investments FY 2025 · Dec 31, 2024 $0
Cash And Equivalents FY 2025 · Dec 31, 2025 $82.98M
Cash And Equivalents FY 2025 · Dec 31, 2024 $163.96M
Stockholders Equity FY 2025 · Dec 31, 2025 $112.05M
Stockholders Equity FY 2025 · Dec 31, 2024 $152.34M
Stockholders Equity FY 2025 · Dec 31, 2023 $236.2M
Current Liabilities FY 2025 · Dec 31, 2025 $50.15M
Current Liabilities FY 2025 · Dec 31, 2024 $27.09M
Total Liabilities FY 2025 · Dec 31, 2025 $53.03M
Total Liabilities FY 2025 · Dec 31, 2024 $32.71M
Current Assets FY 2025 · Dec 31, 2025 $138.87M
Current Assets FY 2025 · Dec 31, 2024 $166.68M
Total Assets FY 2025 · Dec 31, 2025 $165.08M
Total Assets FY 2025 · Dec 31, 2024 $185.05M
Eps Diluted FY 2025 · Dec 31, 2025 −$2.10
Eps Diluted FY 2025 · Dec 31, 2024 −$2.34
Eps Basic FY 2025 · Dec 31, 2025 −$2.10
Eps Basic FY 2025 · Dec 31, 2024 −$2.34
Sga Expense FY 2025 · Dec 31, 2025 $29.57M
Sga Expense FY 2025 · Dec 31, 2024 $27.94M
Rd Expense FY 2025 · Dec 31, 2025 $142.67M
Rd Expense FY 2025 · Dec 31, 2024 $97.2M
Net Income FY 2025 · Dec 31, 2025 −$167.86M
Net Income FY 2025 · Dec 31, 2024 −$115.86M
Operating Income FY 2025 · Dec 31, 2025 −$172.24M
Operating Income FY 2025 · Dec 31, 2024 −$125.14M